Cytostatic and antiviral activity evaluations of hydroxamic derivatives of some non-steroidal anti-inflammatory drugs. 2009

Zrinka Rajic, and Ivan Butula, and Branka Zorc, and Sandra Kraljevic Pavelic, and Karlo Hock, and Kresimir Pavelic, and Lieve Naesens, and Erik De Clercq, and Jan Balzarini, and Monika Przyborowska, and Tadeusz Ossowski, and Mladen Mintas
Faculty of Pharmacy and Biochemistry, University of Zagreb, HR-10000 Zagreb, Croatia.

Non-steroidal anti-inflammatory drugs (NSAID) pharmacophores are interesting in designing potential anticancer drugs. Indeed, numerous experimental, epidemiologic and clinical studies suggest that NSAIDs are promising anticancer drugs. Herein, NSAID hydroxamic acids 3a-i were prepared by a new synthetic procedure and evaluated for their antiviral and cytostatic activity against malignant tumor cell lines and normal human fibroblasts (WI38). Antiviral activity evaluation results indicated that 3f had only a minor activity against the influenza virus A/H1N1 subtype with a selectivity index of 7-10. On the other hand, the results of the in vitro cytostatic activity evaluations revealed that the majority of NSAID hydroxamic acid derivatives 3a-i exhibited a strong non-specific antiproliferative effect at the highest concentration (100 microM) on the tested cell line panel. Only compounds 3b, 3e and 3i exerted a differential dose-dependent inhibitory activity against the growth of HeLa cells (p < 0.05) at concentration 10 microM. Among those three compounds, only compound 3b showed a selective cytostatic effect on HeLa in comparison with normal fibroblasts.

UI MeSH Term Description Entries
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006877 Hydroxamic Acids A class of weak acids with the general formula R-CONHOH. Hydroxamic Acid,Acid, Hydroxamic,Acids, Hydroxamic
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D054697 Cytostatic Agents Compounds that inhibit or prevent the proliferation of CELLS. Cytostatic,Cytostatic Agent,Cytostatic Drug,Cytostatic Drugs,Cytostatics,Agent, Cytostatic,Drug, Cytostatic

Related Publications

Zrinka Rajic, and Ivan Butula, and Branka Zorc, and Sandra Kraljevic Pavelic, and Karlo Hock, and Kresimir Pavelic, and Lieve Naesens, and Erik De Clercq, and Jan Balzarini, and Monika Przyborowska, and Tadeusz Ossowski, and Mladen Mintas
March 1969, The Journal of general virology,
Zrinka Rajic, and Ivan Butula, and Branka Zorc, and Sandra Kraljevic Pavelic, and Karlo Hock, and Kresimir Pavelic, and Lieve Naesens, and Erik De Clercq, and Jan Balzarini, and Monika Przyborowska, and Tadeusz Ossowski, and Mladen Mintas
September 1979, Biochemical pharmacology,
Zrinka Rajic, and Ivan Butula, and Branka Zorc, and Sandra Kraljevic Pavelic, and Karlo Hock, and Kresimir Pavelic, and Lieve Naesens, and Erik De Clercq, and Jan Balzarini, and Monika Przyborowska, and Tadeusz Ossowski, and Mladen Mintas
May 1987, Nihon rinsho. Japanese journal of clinical medicine,
Zrinka Rajic, and Ivan Butula, and Branka Zorc, and Sandra Kraljevic Pavelic, and Karlo Hock, and Kresimir Pavelic, and Lieve Naesens, and Erik De Clercq, and Jan Balzarini, and Monika Przyborowska, and Tadeusz Ossowski, and Mladen Mintas
May 1987, Nihon rinsho. Japanese journal of clinical medicine,
Zrinka Rajic, and Ivan Butula, and Branka Zorc, and Sandra Kraljevic Pavelic, and Karlo Hock, and Kresimir Pavelic, and Lieve Naesens, and Erik De Clercq, and Jan Balzarini, and Monika Przyborowska, and Tadeusz Ossowski, and Mladen Mintas
June 2008, Chemical biology & drug design,
Zrinka Rajic, and Ivan Butula, and Branka Zorc, and Sandra Kraljevic Pavelic, and Karlo Hock, and Kresimir Pavelic, and Lieve Naesens, and Erik De Clercq, and Jan Balzarini, and Monika Przyborowska, and Tadeusz Ossowski, and Mladen Mintas
May 1987, Nihon rinsho. Japanese journal of clinical medicine,
Zrinka Rajic, and Ivan Butula, and Branka Zorc, and Sandra Kraljevic Pavelic, and Karlo Hock, and Kresimir Pavelic, and Lieve Naesens, and Erik De Clercq, and Jan Balzarini, and Monika Przyborowska, and Tadeusz Ossowski, and Mladen Mintas
May 1987, Nihon rinsho. Japanese journal of clinical medicine,
Zrinka Rajic, and Ivan Butula, and Branka Zorc, and Sandra Kraljevic Pavelic, and Karlo Hock, and Kresimir Pavelic, and Lieve Naesens, and Erik De Clercq, and Jan Balzarini, and Monika Przyborowska, and Tadeusz Ossowski, and Mladen Mintas
December 2013, Tropical biomedicine,
Zrinka Rajic, and Ivan Butula, and Branka Zorc, and Sandra Kraljevic Pavelic, and Karlo Hock, and Kresimir Pavelic, and Lieve Naesens, and Erik De Clercq, and Jan Balzarini, and Monika Przyborowska, and Tadeusz Ossowski, and Mladen Mintas
June 1987, Australian family physician,
Zrinka Rajic, and Ivan Butula, and Branka Zorc, and Sandra Kraljevic Pavelic, and Karlo Hock, and Kresimir Pavelic, and Lieve Naesens, and Erik De Clercq, and Jan Balzarini, and Monika Przyborowska, and Tadeusz Ossowski, and Mladen Mintas
January 1967, Progress in medicinal chemistry,
Copied contents to your clipboard!